T1DM Clinical Trials

4 recruiting

T1DM Trials at a Glance

10 actively recruiting trials for t1dm are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Minneapolis, Aurora, and Indianapolis. Lead sponsors running t1dm studies include COUR Pharmaceutical Development Company, Inc., Chulalongkorn University, and Assaf-Harofeh Medical Center.

Browse t1dm trials by phase

About T1DM Clinical Trials

Looking for clinical trials for T1DM? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new T1DM trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about T1DM clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Early Phase 1

Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes

T1DM - Type 1 Diabetes Mellitus
Shanghai Zhongshan Hospital9 enrolled1 locationNCT07528105
Recruiting
Phase 1Phase 2

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Type 1 DiabetesType 1 Diabetes MellitusType 1 Diabetes Mellitis+7 more
COUR Pharmaceutical Development Company, Inc.72 enrolled31 locationsNCT06783309
Recruiting

Type 1 Diabetes Extension Study

Type 1 Diabetes MellitusT1DT1DM
National Institute of Allergy and Infectious Diseases (NIAID)111 enrolled12 locationsNCT02734277
Recruiting
Not Applicable

Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

Type 1 Diabetes Mellitus (T1DM)Type 2 Diabetes Mellitus (T2DM)Hyperglycemia
Vanderbilt University Medical Center60 enrolled1 locationNCT06852950
Recruiting
Phase 1Phase 2

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

Metabolic DiseaseDiabetes Mellitus, Type 1Type 1 Diabetes+14 more
Otsuka Pharmaceutical Factory, Inc.13 enrolled1 locationNCT06575426
Recruiting
Not Applicable

Thai PainPREDICT Validation Study

Type 1 Diabetes Mellitus (T1DM)Type 2 Diabetes Mellitus (T2DM)Neuropathic Pain+3 more
Chulalongkorn University277 enrolled1 locationNCT07195045
Recruiting

Cardiovascular Risk in Children With Chronic Conditions Study

Obesity and OverweightLymphomaLeukemia+13 more
Semmelweis University300 enrolled3 locationsNCT07086989
Recruiting
Not Applicable

The Effect of Hedia Diabetes Assistant on TiMe-in-range in People With Type 1 Diabetes and Sub-Optimal Glycemic Control in France - A Randomised Controlled Trial.

Type 1 Diabetes Mellitus (T1DM)
Hedia ApS154 enrolled6 locationsNCT06819306
Recruiting
Not Applicable

Structured Education Program and Glycemic Control in Adolescents With Type 1 Diabetes

Type 1 Diabetes Mellitus (T1DM)Type 1 Diabetes (T1D)
Dasman Diabetes Institute128 enrolled1 locationNCT06984133
Recruiting
Not Applicable

Efficacy of Hyperbaric Oxygen Therapy (HBOT) in New-onset Type-1 Diabetes Mellitus

T1DM
Assaf-Harofeh Medical Center36 enrolled2 locationsNCT04412200